Optimal Dosage of Remifentanil for Vertebroplasty

Clinical trial NCT05876039 · COMPLETED

Trial details

NCT number: NCT05876039
Sponsor: Tri-Service General Hospital (TSGH)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Remifentanil Analgesia

Start date: 2023-05-20
Primary completion: 2024-08-24
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.